Royal Bank of Canada »

Connect Biopharma Hldgs shares owned by Royal Bank of Canada

Quarter-by-quarter ownership of Connect Biopharma Hldgs (CNTB) shares owned by Royal Bank of Canada from 13F filings

Historical chart of Royal Bank of Canada investment in Connect Biopharma Hldgs

Tip: Access up to 7 years of quarterly data

All positions including Connect Biopharma Hldgs held by Royal Bank of Canada consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Connect Biopharma Hldgs by Royal Bank of Canada

Quarter filed Position value Share count Share price at filing
2026-03-31 $106k 40k 2.62

More positions owned by Royal Bank of Canada

Apple (AAPL)
NVIDIA Corporation (NVDA)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Microsoft Corporation (MSFT)
Ishares Tr Core S&p500 Etf (IVV)
Rbc Cad (RY)
Toronto Dominion Bk Ont Com New (TD)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Bank Of Montreal Cadcom (BMO)
Broadcom (AVGO)
JPMorgan Chase & Co. (JPM)
Cibc Cad (CM)
Canadian Natural Resources (CNQ)
Alphabet Cap Stk Cl C (GOOG)

View all positions for Royal Bank of Canada

Top funds holding Connect Biopharma Hldgs

Ikarian Capital
Boothbay Fund Management
683 Capital Management
Perceptive Advisors
ADAR1 Capital Management
Richmond Brothers
Millennium Management
BML Capital Management
Knott David M Jr
Susquehanna International
Stonepine Capital Management
Propel Bio Management
Diadema Partners
Burkehill Global Management
Renaissance Technologies

View all funds holding Connect Biopharma Hldgs